Handmade ginger pills for type 2 diabetes

Phase II Trial Based Handmade Ginger Pills for T2DM management, Yaoundé, Cameroon.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR201907728547912

Enrollment

Registered

2019-07-22

Start date

2016-01-30

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine

Interventions

Pills ingestion first dose

Follow up second

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -National Center of Obesity Patients, 21 years old or above, with diagnosed Type 2 diabetes -Patients with a least of 3 months period stable diabetes treatment. - Patients with HbA1c level (glycohemoglobin) between 6% and 8%.

Exclusion criteria

Exclusion criteria: -Patients with severe infection(s) -Patients following treatments that could modify the insulin sensitivity or insulin resistance (corticoids, hormonal contraceptives, tabagism)

Design outcomes

Primary

Measure	Time frame
Improving Insulin Sensitivity	—

Secondary

Measure	Time frame
Good appreciation of the pills palatability	—

Countries

Cameroon

Contacts

Public ContactMartin Therese Cheteu Wabo

Harbin Medical University

wabomartin@yahoo.fr008613204660282

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026